Market Overview

Valeant Pharmaceuticals Announces Continuance

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) today announced that, effective August 9, 2013, it has continued from the federal jurisdiction of Canada to the Province of British Columbia (the "Continuance") pursuant to a resolution passed by shareholders of the Company at the annual meeting held May 21, 2013.  The Continuance results in the Company becoming subject to all of the provisions of the British Columbia Business Corporations Act.

See full press release

Posted-In: News Guidance Contracts Management Global

 

Most Popular

Related Articles (VRX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters